ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 7,130.00
-210.00 (-2.86%)
At close: Apr 9, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 532.45 billion as of April 10, 2026.
Market Cap
532.45B
Enterprise Value
509.08B
Revenue
111.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
7,130.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 532.45B, a decrease of -2.76%. That is a compound annual growth rate of -3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 532.45B | -44.86% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.13T |
| Myung In Pharmaceutical LTD. | 830.74B |
| Samyang Biopharm | 576.28B |
| HEM Pharma | 449.67B |
| CellBion | 405.48B |
| DAE HWA Pharmaceutical | 247.86B |
| NOVAREX | 240.93B |
| GREEN CROSS WellBeing | 234.24B |